Physician profile
Matthew D Wright
NPI 1760725949
$3,937.10
in general payments reported to CMS, 2019-2025
18 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $351 · 2022: $285 · 2023: $746 · 2024: $764 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,945.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $1,191.40 | 2024-2025 | Novosorb Btm |
| Davol INC. | $410.65 | 2023 | Phasix Mesh, Arista Ah Flexitip |
| Avita Medical Americas, LLC | $353.61 | 2023-2025 | Recell |
| W. L. Gore & Associates, INC. | $240.35 | 2024 | Gore Septal Occluder |
| Ethicon INC. | $230.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $221.36 | 2019-2024 | Xarelto |
| Kerecis Limited | $206.90 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.87 | 2019-2022 | |
| Sientra, INC. | $178.05 | 2022 | |
| Rti Surgical, INC | $135.83 | 2025 | |
| Acell, INC. | $125.00 | 2019 | |
| Becton, Dickinson and Company | $114.87 | 2024 | Phasix Mesh |
| Kci USA, INC. | $102.92 | 2023 | Prevena, V.A.C. Veraflo |
| Medtronic, INC. | $99.40 | 2023 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $58.26 | 2019-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.59 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $22.56 | 2025 | |
| Amgen INC. | $17.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.